Brand & Product Security

Patient Outcomes Research Moves Drug Development Beyond Clinical Results

‘Print on demand’ changes traditional design, production and inventory practices for labels, inserts and other printed packaging

While nurses move into a more central role in prescribing and administering pharmaceuticals, the nursing professions debate industry influence

As legislative mandates have receded, manufacturers must undertake their own initiatives for protecting against counterfeits and diversion

Central nervous system (CNS) medication for society’s oldest and youngest present special challenges

Antipsychotic and antidepressant drugs have risen to the top categories of prescribed medications in a challenging and risky medical and regulatory arena

States continue to push for a ‘bio-economic’ foundation

States continue to push for a ‘bio-economic’ foundation

Drugmakers recalibrate anti-counterfeiting and serialization efforts

Mature product franchises and mixed clinical outcomes have not dissuaded pharma companies from expending marketing resources for cardiovascular disease treatment

Biopharmaceutical manufacturers turn to a direct-distribution model to leverage opportunities for cost-effective drug delivery and personalized health management services